Global Guide RNA Market Growth (Status and Outlook) 2024-2030

Global Guide RNA Market Growth (Status and Outlook) 2024-2030

gRNA serves as a critical component in CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology, which enables targeted modification of genes. It is usually combined with specific enzymes (such as Cas9 or other Cas proteins in the CRISPR-Cas system) to form an RNA-protein complex for precise recognition and cutting of specific sequences on the DNA chain.This revolutionary technology has applications across various sectors, including agriculture, healthcare, and research. In agriculture, the use of gRNA in CRISPR-based genome editing has the potential to revolutionize crop improvement by enhancing traits such as yield, resistance to diseases, and nutritional content. The healthcare industry is also witnessing a surge in the adoption of gRNA technology for therapeutic purposes, including the development of novel treatments for genetic disorders and cancers. The versatility of gRNA allows scientists and researchers to precisely target and modify specific genes, opening up possibilities for personalized medicine.

The global Guide RNA market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Guide RNA Industry Forecast” looks at past sales and reviews total world Guide RNA sales in 2022, providing a comprehensive analysis by region and market sector of projected Guide RNA sales for 2023 through 2029. With Guide RNA sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Guide RNA industry.

This Insight Report provides a comprehensive analysis of the global Guide RNA landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Guide RNA portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Guide RNA market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Guide RNA and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Guide RNA.

United States market for Guide RNA is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Guide RNA is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Guide RNA is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Guide RNA players cover Thermo Fisher Scientific, Agilent Technologies, System Biosciences, Jena Bioscience GmbH, Merck KGaA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Guide RNA market by product type, application, key players and key regions and countries.

Segmentation by Type:
sgRNA
Guide RNA in RNA Editing
Others

Segmentation by Application:
Bioengineering
Medicine
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
sgRNA
Guide RNA in RNA Editing
Others

Segmentation by Application:
Bioengineering
Medicine
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Agilent Technologies
System Biosciences
Jena Bioscience GmbH
Merck KGaA
Azenta
Takara Bio
Synbio Technologies
Revvity
Synthego Corporation
GenScript Biotech Corporation
Omicsbio
SBS Genetech

Please note: The report will take approximately 2 business days to prepare and deliver.